首页 | 本学科首页   官方微博 | 高级检索  
     


Rapid improvements in health‐related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER‐2 and UNCOVER‐3
Authors:C.L. Leonardi  A. Blauvelt  H.L. Sofen  M. Gooderham  M. Augustin  R. Burge  B. Zhu  K. Reich
Affiliation:1. Central Dermatology, St Louis, MO, USA;2. Oregon Medical Research Center, Portland, OR, USA;3. Department of Medicine (Dermatology), David Geffen School of Medicine, Los Angeles, CA, USA;4. SKiN Centre for Dermatology and Queen's University, Peterborough, ON, Canada;5. Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg, Hamburg, Germany;6. Eli Lilly and Company, Indianapolis, IN, USA;7. University of Cincinnati, Cincinnati, OH, USA;8. Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号